ENTA Enanta Pharmaceuticals, Inc. Stock Quote

ENTA [NASD]

Index	-	P/E	-	EPS (ttm)	-3.68	Insider Own	1.60%	Shs Outstand	20.17M	Perf Week	0.45%
Market Cap	828.24M	Forward P/E	-	EPS next Y	-5.11	Insider Trans	0.00%	Shs Float	17.88M	Perf Month	-12.17%
Income	-74.00M	PEG	-	EPS next Q	-1.28	Inst Own	96.60%	Short Float	9.73%	Perf Quarter	-16.45%
Sales	94.20M	P/S	8.79	EPS this Y	-182.00%	Inst Trans	-1.10%	Short Ratio	12.53	Perf Half Y	-11.89%
Book/sh	21.62	P/B	1.94	EPS next Y	-27.60%	ROA	-15.20%	Target Price	68.14	Perf Year	-13.97%
Cash/sh	19.06	P/C	2.20	EPS next 5Y	-	ROE	-16.20%	52W Range	40.32 - 56.97	Perf YTD	-0.24%
Dividend	-	P/FCF	-	EPS past 5Y	-19.60%	ROI	-9.40%	52W High	-26.28%	Beta	0.38
Dividend %	-	Quick Ratio	16.10	Sales past 5Y	-5.30%	Gross Margin	-	52W Low	4.17%	ATR	1.41
Employees	141	Current Ratio	16.10	Sales Q/Q	-27.20%	Oper. Margin	-89.90%	RSI (14)	39.76	Volatility	3.21% 3.34%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	-262.60%	Profit Margin	-78.60%	Rel Volume	1.00	Prev Close	41.02
Shortable	Yes	LT Debt/Eq	0.00	Earnings	May 06 AMC	Payout	-	Avg Volume	138.87K	Price	42.00
Recom	2.50	SMA20	-3.34%	SMA50	-9.24%	SMA200	-11.06%	Volume	138,225	Change	2.39%

Jan-29-21

Upgrade

JP Morgan

Underweight → Neutral

$55

Nov-24-20

Initiated

Evercore ISI

Underperform

$30

Aug-28-20

Resumed

ROTH Capital

Buy

$104

Aug-26-20

Initiated

Piper Sandler

Overweight

$87

Jul-27-20

Upgrade

JMP Securities

Mkt Perform → Mkt Outperform

$70

Mar-17-20

Upgrade

Robert W. Baird

Neutral → Outperform

$60

Nov-22-19

Downgrade

JMP Securities

Mkt Outperform → Mkt Perform

Sep-26-19

Downgrade

JP Morgan

Neutral → Underweight

$86 → $57

May-24-19

Initiated

Wolfe Research

Outperform

$117

Apr-23-19

Upgrade

Berenberg

Hold → Buy

$80 → $120

Dec-13-18

Initiated

Berenberg

Hold

$80

Jun-06-18

Initiated

ROTH Capital

Buy

$133

Feb-08-18

Downgrade

JP Morgan

Overweight → Neutral

Jan-02-18

Downgrade

RBC Capital Mkts

Outperform → Sector Perform

Nov-21-17

Reiterated

RBC Capital Mkts

Outperform

$54 → $58

Sep-15-17

Initiated

RBC Capital Mkts

Outperform

$54

Jul-11-17

Upgrade

JMP Securities

Mkt Perform → Mkt Outperform

Apr-28-16

Downgrade

JMP Securities

Mkt Outperform → Mkt Perform

Feb-09-16

Reiterated

Barclays

Underweight

$16 → $18

Oct-23-15

Upgrade

JMP Securities

Mkt Perform → Mkt Outperform

$32

Jul-14-21 05:30PM	Enanta Pharmaceuticals Announces the Planned Retirement of Chief Medical Officer Nathalie Adda, M.D. Business Wire
Jun-23-21 02:01AM	Enanta Pharmaceuticals Presents New Data for EDP-721, an Oral Hepatitis B Virus RNA Destabilizer, at the European Association for the Study of the Liver (EASL) International Liver Congress Business Wire
Jun-22-21 04:01PM	Enanta Pharmaceuticals Reports Positive Data from Phase 1b Study of EDP-514, a Hepatitis B Virus (HBV) Core Inhibitor, in Viremic Chronic HBV Patients Business Wire
Jun-10-21 07:00AM	Enanta Pharmaceuticals to Participate in Two Investor Conferences in June Business Wire
Jun-03-21 07:00AM	Enanta Pharmaceuticals to Present Preclinical Data for EDP-721, its Novel Oral Hepatitis B Virus RNA Destabilizer, at the International Liver Congress 2021 Sponsored by the European Association for the Study of the Liver Business Wire
May-11-21 07:00AM	Enanta Pharmaceuticals to Present at the RBC Capital Markets Global Healthcare Conference Business Wire
May-07-21 09:58AM	Enanta's EDP-514 Four-Week Treatment Shows Around 10 Time Reduction In Hepatitis B Virus RNA Benzinga
05:01AM	Enanta Pharmaceuticals Inc (ENTA) Q2 2021 Earnings Call Transcript Motley Fool
May-06-21 05:45PM	Enanta Pharmaceuticals (ENTA) Reports Q2 Loss, Lags Revenue Estimates Zacks
04:01PM	Enanta Pharmaceuticals Reports Positive Data from Part 2 of its Phase 1b Study of EDP-514 in Chronic Hepatitis B Virus Patients on Treatment with a Nucleoside Reverse Transcriptase Inhibitor Business Wire
04:01PM	Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2021 with Webcast and Conference Call Today at 4:30 p.m. ET Business Wire
02:45PM	Enanta Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Apr-29-21 07:00AM	Enanta to Host Conference Call on May 6 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Second Quarter Ended March 31, 2021 Business Wire
Apr-28-21 12:33PM	Analysts Estimate Enanta Pharmaceuticals (ENTA) to Report a Decline in Earnings: What to Look Out for Zacks
Mar-02-21 07:01AM	Enanta Pharmaceuticals to Present at Upcoming Investor Conferences Business Wire
Feb-18-21 04:02PM	Enanta Pharmaceuticals to Present at SVB Leerink 10th Annual Global Healthcare Conference Business Wire
Feb-08-21 11:00PM	Enanta Pharmaceuticals Inc (ENTA) Q1 2021 Earnings Call Transcript Motley Fool
05:25PM	Enanta Pharmaceuticals (ENTA) Reports Q1 Loss, Tops Revenue Estimates Zacks
05:06PM	Recap: Enanta Pharmaceuticals Q1 Earnings Benzinga
04:02PM	Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2020 with Webcast and Conference Call Today at 4:30 p.m. ET Business Wire
02:30PM	Enanta Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Feb-05-21 10:09AM	Earnings Preview: Enanta Pharmaceuticals Benzinga
Feb-01-21 04:02PM	Enanta Pharmaceuticals to Host Conference Call on February 8 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal First Quarter Ended December 31, 2020 Business Wire
Jan-28-21 12:32PM	Earnings Preview: Enanta Pharmaceuticals (ENTA) Q1 Earnings Expected to Decline Zacks -5.88%
Jan-26-21 07:00AM	Enanta Pharmaceuticals Announces the Appointment of Brendan Luu as Senior Vice President, Business Development Business Wire
Jan-08-21 07:01AM	Enanta Pharmaceuticals to Provide Updates on its Research and Development Programs and Outlook for 2021 at the 39th Annual J.P. Morgan Healthcare Conference Business Wire
Jan-05-21 07:01AM	Enanta Pharmaceuticals Announces the Appointment of John P. DeVincenzo, M.D. as Vice President of Translational Virology Business Wire
06:00AM	Enanta Pharmaceuticals to Present at the 39th Annual J.P. Morgan Healthcare Conference Business Wire
Dec-19-20 10:40PM	Is ENTA A Good Stock To Buy Now According To Hedge Funds? Insider Monkey
Dec-08-20 07:01AM	Enanta Pharmaceuticals Announces the Appointment of Tara L. Kieffer, Ph.D. as Senior Vice President, New Product Strategy and Development Business Wire
Nov-25-20 12:10AM	Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Just Reported Earnings, And Analysts Cut Their Target Price Simply Wall St.
Nov-23-20 10:00PM	Enanta Pharmaceuticals Inc (ENTA) Q4 2020 Earnings Call Transcript Motley Fool
05:35PM	Enanta Pharmaceuticals (ENTA) Reports Q4 Loss, Misses Revenue Estimates Zacks
04:19PM	Enanta Pharmaceuticals: Q4 Earnings Insights Benzinga
04:01PM	Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year Ended September 30, 2020 Business Wire
02:15PM	Enanta Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Nov-20-20 10:03AM	Earnings Preview: Enanta Pharmaceuticals Benzinga
Nov-18-20 07:02AM	Enanta Pharmaceuticals to Present at Upcoming Investor Conferences Business Wire
Nov-16-20 07:02AM	Enanta Pharmaceuticals to Host Conference Call on November 23 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Fourth Quarter and Year Ended September 30, 2020 Business Wire
Nov-12-20 12:30PM	Analysts Estimate Enanta Pharmaceuticals (ENTA) to Report a Decline in Earnings: What to Look Out for Zacks
Oct-27-20 09:54AM	New Strong Sell Stocks for October 27th Zacks
Oct-12-20 01:27PM	Is Enanta Pharmaceuticals Inc (ENTA) Going to Burn These Hedge Funds? Insider Monkey
Sep-28-20 07:00AM	Enanta Pharmaceuticals to Present at the 4th Annual H.C. Wainwright Virtual NASH Investor Conference Business Wire
Sep-14-20 07:00AM	Enanta Pharmaceuticals Initiates Phase 1 Clinical Study of EDP-297, its Highly Potent and Targeted Follow-On Farnesoid X Receptor Agonist for the Treatment of Non-Alcoholic Steatohepatitis Business Wire
Sep-03-20 07:01AM	Enanta Pharmaceuticals to Participate in Upcoming September Conferences Business Wire
Aug-28-20 06:15AM	Enanta Pharmaceuticals Presents New Data from its Hepatitis B and Non-Alcoholic Steatohepatitis Programs at the Digital International Liver Congress 2020 Business Wire
Aug-26-20 09:42AM	Benzinga's Top Upgrades, Downgrades For August 26, 2020 Benzinga
Aug-20-20 07:00AM	Enanta Pharmaceuticals Announces Data Presentations at the European Association for the Study of the Liver (EASL) Digital International Liver Congress 2020 Business Wire
Aug-07-20 09:28AM	Were Hedge Funds Right About Ditching Enanta Pharmaceuticals Inc (ENTA)? Insider Monkey
Aug-05-20 01:31AM	Enanta Pharmaceuticals Inc (ENTA) Q3 2020 Earnings Call Transcript Motley Fool
Aug-04-20 06:35PM	Enanta Pharmaceuticals (ENTA) Reports Q3 Loss, Misses Revenue Estimates Zacks
04:21PM	Recap: Enanta Pharmaceuticals Q3 Earnings Benzinga
04:01PM	Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter Ended June 30, 2020 with Webcast and Conference Call Today at 4:30 p.m. ET Business Wire
Aug-03-20 07:02AM	Enanta Pharmaceuticals to Present at the BTIG Virtual Biotechnology Conference 2020 Business Wire
Jul-28-20 12:32PM	Analysts Estimate Enanta Pharmaceuticals (ENTA) to Report a Decline in Earnings: What to Look Out for Zacks
07:01AM	Enanta Pharmaceuticals to Host Conference Call on August 4 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Third Quarter Ended June 30, 2020 Business Wire
Jul-17-20 01:41PM	Are Enanta Pharmaceuticals, Inc.'s (NASDAQ:ENTA) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market? Simply Wall St.
Jul-09-20 07:01AM	Enanta Pharmaceuticals Announces Clinical Trial Progress for EDP-514, its Lead Core Inhibitor for Hepatitis B Virus Business Wire
Jun-29-20 07:00AM	Enanta Pharmaceuticals Announces the Appointment of Mark G. Foletta to Its Board of Directors Business Wire
Jun-23-20 12:23PM	Hedge Funds Are Selling Enanta Pharmaceuticals Inc (ENTA) Insider Monkey
Jun-11-20 07:02AM	Enanta Pharmaceuticals to Present at the Raymond James Human Health Innovation Conference Business Wire -5.74%
Jun-04-20 10:20PM	Edited Transcript of ENTA earnings conference call or presentation 6-May-20 8:30pm GMT Thomson Reuters StreetEvents
May-23-20 09:58AM	If You Had Bought Enanta Pharmaceuticals (NASDAQ:ENTA) Stock Three Years Ago, You Could Pocket A 84% Gain Today Simply Wall St.
May-14-20 08:53AM	Why Enanta Pharmaceuticals (ENTA) Stock Might be a Great Pick Zacks
May-12-20 07:30AM	Enanta Pharmaceuticals to Present at the 2020 RBC Capital Markets Global Healthcare Virtual Conference Business Wire
May-09-20 09:43PM	Were Hedge Funds Right About Enanta Pharmaceuticals Inc (ENTA)? Insider Monkey
May-07-20 12:01AM	Enanta Pharmaceuticals Inc (ENTA) Q2 2020 Earnings Call Transcript Motley Fool
May-06-20 06:45PM	Enanta Pharmaceuticals (ENTA) Reports Q2 Loss, Misses Revenue Estimates Zacks
04:03PM	Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2020 with Webcast and Conference Call Today at 4:30 p.m. ET Business Wire
04:03PM	Enanta Announces Results of INTREPID Study of EDP-305 for the Treatment of Primary Biliary Cholangitis Business Wire
Apr-29-20 12:34PM	Analysts Estimate Enanta Pharmaceuticals (ENTA) to Report a Decline in Earnings: What to Look Out for Zacks
Apr-28-20 04:05PM	Enanta to Host Conference Call on May 6 at 4:30 p.m. ET to Discuss Financial Results for its Fiscal Second Quarter Ended March 31, 2020 Business Wire -7.59%
12:33PM	Analysts Estimate Enanta Pharmaceuticals (ENTA) to Report a Decline in Earnings: What to Look Out for Zacks
Apr-17-20 10:19AM	Is Enanta Pharmaceuticals (NASDAQ:ENTA) Using Too Much Debt? Simply Wall St.
Mar-26-20 04:05PM	Enanta Provides Update on Clinical Development Activities During COVID-19 Pandemic Business Wire +6.63%
Mar-13-20 07:00AM	Enanta Pharmaceuticals Announces Efforts to Discover a Treatment for the Novel Coronavirus Disease COVID-19 Business Wire +9.19%
Mar-06-20 07:05AM	Enantas HCV Collaboration Partner AbbVie Receives Marketing Authorization from European Commission to Shorten MAVIRET® (glecaprevir/pibrentasvir) Duration to Eight Weeks for Treatment-Naïve Genotype 3 HCV Patients with Compensated Cirrhosis Business Wire
Mar-04-20 08:09AM	Does Market Volatility Impact Enanta Pharmaceuticals, Inc.'s (NASDAQ:ENTA) Share Price? Simply Wall St.
Feb-12-20 12:18AM	Edited Transcript of ENTA earnings conference call or presentation 6-Feb-20 9:30pm GMT Thomson Reuters StreetEvents
Feb-06-20 05:15PM	Enanta Pharmaceuticals (ENTA) Q1 Earnings Top Estimates Zacks
04:00PM	Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter and Three Months Ended December 31, 2019 Business Wire
02:30PM	Enanta Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Feb-05-20 04:11PM	13 Key NASH Drug Candidates To Watch For In A Potential $30-Billion Market Benzinga
Feb-03-20 07:27AM	Is Enanta Pharmaceuticals, Inc.'s (NASDAQ:ENTA) High P/E Ratio A Problem For Investors? Simply Wall St.
Jan-30-20 12:31PM	Earnings Preview: Enanta Pharmaceuticals (ENTA) Q1 Earnings Expected to Decline Zacks
Jan-24-20 07:30AM	Enanta to Host Conference Call on February 6 at 4:30 p.m. ET to Discuss Financial Results for its Fiscal First Quarter Ended December 31, 2019 Business Wire
Jan-14-20 05:30AM	AbbVie's MAVIRET® now listed on the Newfoundland and Labrador formulary CNW Group
Jan-09-20 07:30AM	Enanta to Provide Updates on its R&D Programs and Business Outlook for 2020 during the 38th Annual J.P. Morgan Healthcare Conference Business Wire
Jan-04-20 08:44AM	Does This Valuation Of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Imply Investors Are Overpaying? Simply Wall St.
Dec-30-19 07:30AM	Enanta Pharmaceuticals to Present at the 38th Annual J.P. Morgan Healthcare Conference Business Wire
Dec-11-19 11:25AM	Is Enanta Pharmaceuticals Inc (ENTA) A Good Stock To Buy? Insider Monkey
Dec-09-19 07:38AM	Should You Worry About Enanta Pharmaceuticals, Inc.'s (NASDAQ:ENTA) CEO Pay Cheque? Simply Wall St.
Dec-07-19 11:24PM	Edited Transcript of ENTA earnings conference call or presentation 21-Nov-19 9:30pm GMT Thomson Reuters StreetEvents
Nov-22-19 08:18AM	The Daily Biotech Pulse: Roche-Spark Deal Extended Again, Zymeworks' Positive Readout, Enanta Misses Earnings Estimate Benzinga
Nov-21-19 05:15PM	Enanta Pharmaceuticals (ENTA) Lags Q4 Earnings and Revenue Estimates Zacks
04:00PM	Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year Ended September 30, 2019 Business Wire
07:22AM	The Daily Biotech Pulse: Patent Win For Cellectis, Hepion Proves Efficacy In Animal Model, Job Cuts At Neon Benzinga
Nov-17-19 08:42AM	The Week Ahead In Biotech: Clinical Readouts In Focus As Earnings Wind Down Benzinga
Nov-14-19 10:30AM	Analysts Estimate Enanta Pharmaceuticals (ENTA) to Report a Decline in Earnings: What to Look Out for Zacks
Nov-11-19 10:21AM	Is Enanta Pharmaceuticals, Inc.'s (NASDAQ:ENTA) 14% ROE Worse Than Average? Simply Wall St.

Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, non-alcoholic steatohepatitis, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company offers glecaprevir for the treatment of chronic hepatitis C virus, or HCV under the MAVYRET and MAVIRET names. Enanta Pharmaceuticals, Inc. has a collaborative development and license agreement with Abbott Laboratories to identify, develop, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir for the treatment of chronic hepatitis C virus. The company was founded in 1995 and is headquartered in Watertown, Massachusetts.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Or Yat Sun	Sr. VP & CSO	Jan 26	Option Exercise	12.68	13,693	173,576	330,918	Jan 28 05:41 PM
MELLETT PAUL J	Treasurer and CFO	Jan 08	Sale	45.58	6,000	273,463	61,759	Jan 08 08:57 PM
Gardiner Nathaniel S.	Sr. VP & General Counsel	Dec 03	Option Exercise	30.00	1,667	50,010	38,538	Dec 07 05:38 PM
MELLETT PAUL J	Treasurer and CFO	Nov 11	Option Exercise	2.54	3,480	8,849	46,304	Nov 12 04:12 PM
Gardiner Nathaniel S.	Sr. VP & General Counsel	Aug 05	Option Exercise	30.00	1,666	49,980	29,271	Aug 06 04:38 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience